Synth Logo

Get a high resolution logo for any domain or stock ticker — for free

Inventiva S.A. (0RNK) logo

SVG 0.75 KB
Download
https://logo.synthfinance.com/ticker/0RNK
HTML
<img src="https://logo.synthfinance.com/ticker/0RNK" />
About Inventiva S.A. (0RNK)

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.